SEARCH

For those who would like to learn more about the proposed voluntary information sharing (VIS) program

This may lead to the belief that they have no professional obligations towards public safety.

The Ends Versus The Means According to Michael Porter value-based systems derive outcomes from the performance risk and compliance obligations they can be described across the dimensions of the ends versus the means of the outcomes and performance requirements the organization is accountable for achieving them by means However, when the means are specified either in terms of management standards and as prescriptive rules will provide sufficient transparency to support retrospective investigation and analysis in order to learn

Western society (and I will add business in particular) has become overly reliant on the left hemisphere, leading McGilchrist's model of the divided brain offers a compelling lens through which to view these management This tension can be understood through the lens of Iain McGilchrist's theory of the divided brain.

create a competitive advantage by managing their compliance risks more effectively, which can ultimately lead

Confusion rather than certainty will prevail and we all know where that leads.

It can be argued that too much "suggestion" may lead to holding the choice architects rather than the

organizations are appointing a Chief Risk Officer or creating management-level risk committees to help lead

This lack of understanding may lead them to pursue other career paths.

Acceptance Acceptance of risk means that it is acknowledged without measures to address the risk. This strategy is often chosen when the risk is irreducible or no other means are feasible to buy down These may require a higher degree of rigour as the effects may be more immediate and may lead to loss In DOE terms this means promoting the residual risk to the primary risk category along with the inherent Obligations typically have a long life-cycle which means the effectiveness of risk measures should be

Changes made during the product life-cycle can lead to re-validation and conducting more clinical trials provided before the change is implemented; g) provide procedures for emergency changes including a means

This may lead to viewing compliance roles as something that we want to reduce and replace with technology